Rhinomed Ltd. is a medical technology company, which engages in the identification, acquisition, and commercialization of late stage therapeutic delivery technologies. It focuses on research, development and commercialisation of consumer and medical devices. The company was founded on February 9, 2004 and is headquartered in Cremorne, Australia.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Rhinomed Limited market cap is $5.39M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rhinomed Limited 52 week high is $0.0698 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rhinomed Limited 52 week low is $0.004 as of November 18, 2026.
Rhinomed Limited stock price today is $0.019.
Rhinomed Limited stock price yesterday was $0.0169.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Rhinomed Limited's P/E ratio is -0.74.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Rhinomed Limited P/B ratio is -1.2735.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Rhinomed Limited 50-day moving average is $0.0152.